Product Code: 4469
Title:
Surrogacy Market Size By Type (Gestational Surrogacy, Traditional Surrogacy), By Technology (Intrauterine Insemination (IUI), In-vitro Fertilization (IVF) {Classical/Standard IVF, Intracytoplasmic Sperm Injection (ICSI)}, By Age Group (Under 35 Years, 35-37 Years, 38-39 Years, 40-42 Years, 43-44 Years, Over 44 Years), By Service Provider (Hospitals, Fertility Clinics), Industry Analysis Report, Regional, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025.
Surrogacy market is expected to exceed USD 27.5 billion by 2025. Rising number of people suffering from infertility problems will primarily drive the surrogacy market growth over the projected timeframe.
Some major findings of the surrogacy market report include:
Commercial surrogacy is completely banned in majority of countries that has stimulated the growth of altruistic as well as gestational surrogacy to some extent
Technological advancements in assisted reproductive techniques coupled with surging number of infertility cases will drive the demand for surrogacy procedure
Fertility clinics are adopting various strategies to create awareness about the fertility treatments provided by them in order to expand their customer base as well as target couples facing difficulty with pregnancy
Stringent regulations pertaining to commercial surrogacy in major countries has escalated the demand in unregulated markets such as Kenya and Nigeria
Increasing number of people suffering from infertility problems including reduced sperm count, problem in egg/sperm production will act as high impact rendering factor for the growth of surrogacy market. Factors such as hormonal changes, stress, alcohol consumption, steroid use and others has led to rise in infertility cases thereby positively impacting the business growth.
Technological advancements in assisted reproductive technologies, rising awareness regarding infertility treatment and growing number of fertility clinics will drive the surrogacy market growth over the forecast period. However, high cost related to the procedure along with stringent regulations pertaining to surrogacy in several countries will restrict the growth of market over the coming years.
There are two types of surrogacy, namely, gestational and traditional surrogacy. Gestational surrogacy dominated in the industry in 2018 and is estimated to grow by 24.8% over the forecast period. High adoption of gestational technique by surrogacy professionals along with technological advancements will drive the segment growth. Emotional and legal complexities associated with traditional surrogacy has further propelled the adoption of gestational surrogacy method driving the overall industry growth
Based on technology, the industry is segmented into in-vitro fertilization (IVF), intrauterine insemination (IUI) and others. In-vitro fertilization segment accounted for over 60% revenue share in 2018 and is further bifurcated into classical/standard IVF and intracytoplasmic sperm injection (ICSI). Increasing number of infertility cases, high adoption of in-vitro fertilization services and growing tendency of women freezing their eggs to have child in later stage will drive the segmental growth over the forthcoming years.
The age-group segment includes below 35 years, 35-37 years, 38-39 years, 40-42 years, 43-44 years, and over 44 years. 38-39 years age group segment will witness 24.0% CAGR during the forecast period owing to increasing number of women suffering from fertility problems resulting in difficulty in sustaining pregnancy or getting pregnant. The fertility rate in developed countries is usually low due to lifestyle choices, easy availability of birth control measures and economic affluence.
The service provider segment includes fertility clinics, hospitals and others. Increasing awareness about infertility treatments available in the market, growing number of fertility centers and fertility specialists will drive the fertility centers segment to reach USD 17.7 billion by 2025. Rising disposable income coupled with increasing healthcare expenditure will positively impact the industry growth.
Nova IVI Fertility (NIF), New Hope Fertility Center, Ovation Fertility, IVI-RMA GLOBAL, AVA Clinic Scanfert, Extraordinary Conceptions and Bangkok IVF Center are some of the notable industry players providing infertility treatment. These market players are engaged in undertaking various initiatives to create awareness about infertility treatment and expand their customer base. For instance, Merck Serono, a pharmaceutical company launched a social health initiative in March 2016 to educate and raise awareness about solutions to fix infertility issues among the couples facing such type of concerns.
Table of Contents
Chapter 1. Methodology
- 1.1. Methodology
- 1.1.1. Initial data exploration
- 1.1.2. Statistical model and forecast
- 1.1.3. Industry insights and validation
- 1.1.4. Market definition and forecast parameters
- 1.2. Data sources
- 1.2.1. Secondary
- 1.2.2. Primary
Chapter 2. Executive Summary
- 2.1. Surrogacy industry 360 degree synopsis, 2014 - 2025
- 2.1.1. Business trends
- 2.1.2. Type trends
- 2.1.3. Technology trends
- 2.1.4. Age group trends
- 2.1.5. Service provider trends
- 2.1.6. Regional trends
Chapter 3. Surrogacy Industry Insights
- 3.1. Industry segmentation
- 3.2. Industry landscape, 2014 - 2025 (USD Million)
- 3.3. Industry impact forces
- 3.3.1. Growth drivers
- 3.3.1.1. Increasing number of infertility cases globally
- 3.3.1.2. Rising awareness about the infertility treatment options available in the market
- 3.3.1.3. Growing prevalence of causative factors including hormonal changes, alcohol consumption and others leading to infertility issues
- 3.3.1.4. Increasing number of fertility clinics
- 3.3.2. Industry pitfalls & challenges
- 3.3.2.1. Stringent regulations pertaining commercial surrogacy
- 3.3.2.2. High cost involved in surrogacy procedure
- 3.4. Growth potential analysis
- 3.4.1. By type
- 3.4.2. By technology
- 3.4.3. By age group
- 3.4.4. By service provider
- 3.5. Porter's analysis
- 3.6. Regulatory landscape
- 3.7. Competitive landscape, 2018
- 3.8. PESTEL analysis
Chapter 4. Surrogacy Market, By Type
- 4.1. Key segment trends
- 4.2. Gestational surrogacy
- 4.2.1. Market size, by region, 2014 - 2025 (USD Million)
- 4.3. Traditional surrogacy
- 4.3.1. Market size, by region, 2014 - 2025 (USD Million)
Chapter 5. Surrogacy Market, By Technology
- 5.1. Key segment trends
- 5.2. Intrauterine insemination (IUI)
- 5.2.1. Market size, by region, 2014 - 2025 (USD Million)
- 5.3. In-vitro fertilization (IVF)
- 5.3.1. Market size, by region, 2014 - 2025 (USD Million)
- 5.3.2. Classical/standard IVF
- 5.3.2.1. Market size, by region, 2014 - 2025 (USD Million)
- 5.3.3. Intracytoplasmic sperm injection (ICSI)
- 5.3.3.1. Market size, by region, 2014 - 2025 (USD Million)
- 5.4. Others
- 5.4.1. Market size, by region, 2014 - 2025 (USD Million)
Chapter 6. Surrogacy Market, By Age Group
- 6.1. Key segment trends
- 6.2. Below 35 years
- 6.2.1. Market size, by region, 2014 - 2025 (USD Million)
- 6.3. 35-37 years
- 6.3.1. Market size, by region, 2014 - 2025 (USD Million)
- 6.4. 38 - 39 years
- 6.4.1. Market size, by region, 2014 - 2025 (USD Million)
- 6.5. 40-42 years
- 6.5.1. Market size, by region, 2014 - 2025 (USD Million)
- 6.6. 43-44 years
- 6.6.1. Market size, by region, 2014 - 2025 (USD Million)
- 6.7. Over 44 years
- 6.7.1. Market size, by region, 2014 - 2025 (USD Million)
Chapter 7. Surrogacy Market, By Service provider
- 7.1. Key segment trends
- 7.2. Hospitals
- 7.2.1. Market size, by region, 2014 - 2025 (USD Million)
- 7.3. Fertility clinics
- 7.3.1. Market size, by region, 2014 - 2025 (USD Million)
- 7.4. Others
- 7.4.1. Market size, by region, 2014 - 2025 (USD Million)
Chapter 8. Surrogacy Market, By Region
- 8.1. Key regional trends
- 8.2. North America
- 8.2.1. Market size, by country, 2014 - 2025 (USD Million)
- 8.2.2. Market size, by type, 2014 - 2025 (USD Million)
- 8.2.3. Market size, by technology, 2014 - 2025 (USD Million)
- 8.2.3.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.2.4. Market size, by age group, 2014 - 2025 (USD Million)
- 8.2.5. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.2.6. U.S.
- 8.2.6.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.2.6.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.2.6.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.2.6.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.2.6.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3. Europe
- 8.3.1. Market size, by country, 2014 - 2025 (USD Million)
- 8.3.2. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.3. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.3.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.4. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.5. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3.6. Czech Republic
- 8.3.6.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.6.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.6.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.6.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.6.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3.7. Estonia
- 8.3.7.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.7.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.7.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.7.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.7.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3.8. Georgia
- 8.3.8.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.8.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.8.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.8.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.8.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3.9. Greece
- 8.3.9.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.9.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.9.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.9.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.9.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3.10. Poland
- 8.3.10.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.10.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.10.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.10.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.10.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3.11. Russia
- 8.3.11.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.11.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.11.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.11.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.11.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3.12. Sweden
- 8.3.12.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.12.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.12.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.12.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.12.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3.13. Ukraine
- 8.3.13.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.13.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.13.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.13.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.13.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.3.14. UK
- 8.3.14.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.3.14.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.3.14.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.3.14.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.3.14.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Market size, by country, 2014 - 2025 (USD Million)
- 8.4.2. Market size, by type, 2014 - 2025 (USD Million)
- 8.4.3. Market size, by technology, 2014 - 2025 (USD Million)
- 8.4.3.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.4.4. Market size, by age group, 2014 - 2025 (USD Million)
- 8.4.5. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.4.6. India
- 8.4.6.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.4.6.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.4.6.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.4.6.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.4.6.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.4.7. Thailand
- 8.4.7.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.4.7.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.4.7.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.4.7.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.4.7.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.4.8. South Korea
- 8.4.8.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.4.8.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.4.8.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.4.8.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.4.8.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.5. Africa
- 8.5.1. Market size, by country, 2014 - 2025 (USD Million)
- 8.5.2. Market size, by type, 2014 - 2025 (USD Million)
- 8.5.3. Market size, by technology, 2014 - 2025 (USD Million)
- 8.5.3.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.5.4. Market size, by age group, 2014 - 2025 (USD Million)
- 8.5.5. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.5.6. Kenya
- 8.5.6.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.5.6.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.5.6.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.5.6.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.5.6.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.5.7. Nigeria
- 8.5.7.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.5.7.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.5.7.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.5.7.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.5.7.4. Market size, by service provider, 2014 - 2025 (USD Million)
- 8.5.8. South Africa
- 8.5.8.1. Market size, by type, 2014 - 2025 (USD Million)
- 8.5.8.2. Market size, by technology, 2014 - 2025 (USD Million)
- 8.5.8.2.1. Market size, by in-vitro fertilization, 2014 - 2025 (USD Million)
- 8.5.8.3. Market size, by age group, 2014 - 2025 (USD Million)
- 8.5.8.4. Market size, by service provider, 2014 - 2025 (USD Million)
Chapter 9. Company Profiles
- 9.1. New Hope Fertility Center
- 9.1.1. Business overview
- 9.1.2. Financial data
- 9.1.3. Technology landscape
- 9.1.4. Strategic outlook
- 9.1.5. SWOT analysis
- 9.2. IVI-RMA Global
- 9.2.1. Business overview
- 9.2.2. Financial data
- 9.2.3. Technology landscape
- 9.2.4. Strategic outlook
- 9.2.5. SWOT analysis
- 9.3. Scanfert AVA Clinic
- 9.3.1. Business overview
- 9.3.2. Financial data
- 9.3.3. Technology landscape
- 9.3.4. Strategic outlook
- 9.3.5. SWOT analysis
- 9.4. Bourn Hall Fertility Clinic
- 9.4.1. Business overview
- 9.4.2. Financial data
- 9.4.3. Technology landscape
- 9.4.4. Strategic outlook
- 9.4.5. SWOT analysis
- 9.5. Nova IVI Fertility
- 9.5.1. Business overview
- 9.5.2. Financial data
- 9.5.3. Technology landscape
- 9.5.4. Strategic outlook
- 9.5.5. SWOT analysis
- 9.6. Ovation Fertility
- 9.6.1. Business overview
- 9.6.2. Financial data
- 9.6.3. Technology landscape
- 9.6.4. Strategic outlook
- 9.6.5. SWOT analysis
- 9.7. Bangkok IVF Center
- 9.7.1. Business overview
- 9.7.2. Financial data
- 9.7.3. Technology landscape
- 9.7.4. Strategic outlook
- 9.7.5. SWOT analysis
- 9.8. Extraordinary Conceptions
- 9.8.1. Business overview
- 9.8.2. Financial data
- 9.8.3. Technology landscape
- 9.8.4. Strategic outlook
- 9.8.5. SWOT analysis
- 9.9. Cardone & Associates Reproductive Medicine & Infertility, LLC
- 9.9.1. Business overview
- 9.9.2. Financial data
- 9.9.3. Technology landscape
- 9.9.4. Strategic outlook
- 9.9.5. SWOT analysis
- 9.10. Max Healthcare
- 9.10.1. Business overview
- 9.10.2. Financial data
- 9.10.3. Technology landscape
- 9.10.4. Strategic outlook
- 9.10.5. SWOT analysis
- 9.11. Growing Generations, LLC
- 9.11.1. Business overview
- 9.11.2. Financial data
- 9.11.3. Technology landscape
- 9.11.4. Strategic outlook
- 9.11.5. SWOT analysis
- 9.12. Circle Surrogacy
- 9.12.1. Business overview
- 9.12.2. Financial data
- 9.12.3. Technology landscape
- 9.12.4. Strategic outlook
- 9.12.5. SWOT analysis
- 9.13. Morpheus Life Sciences Pvt. Ltd.
- 9.13.1. Business overview
- 9.13.2. Financial data
- 9.13.3. Technology landscape
- 9.13.4. Strategic outlook
- 9.13.5. SWOT analysis
比較リスト
